Paul T Francis
Paul T Francis
University of Exeter (previously King's College London)
Verified email at
Cited by
Cited by
The cholinergic hypothesis of Alzheimer’s disease: a review of progress
PT Francis, AM Palmer, M Snape, GK Wilcock
Journal of Neurology, Neurosurgery & Psychiatry 66 (2), 137-147, 1999
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ...
Archives of general psychiatry 67 (7), 739-748, 2010
Neurochemical studies of early-onset Alzheimer's disease: possible influence on treatment
PT Francis, AM Palmer, NR Sims, DM Bowen, AN Davison, MM Esiri, ...
New England Journal of Medicine 313 (1), 7-11, 1985
Cholinesterase inhibitors used in the treatment of Alzheimer’s disease: the relationship between pharmacological effects and clinical efficacy
DG Wilkinson, PT Francis, E Schwam, J Payne-Parrish
Drugs & aging 21, 453-478, 2004
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future
YE Geda, LS Schneider, LN Gitlin, DS Miller, GS Smith, J Bell, J Evans, ...
Alzheimer's & dementia 9 (5), 602-608, 2013
Glutamatergic systems in Alzheimer's disease
PT Francis
International journal of geriatric psychiatry 18 (S1), S15-S21, 2003
The interplay of neurotransmitters in Alzheimer's disease
PT Francis
CNS spectrums 10 (S18), 6-9, 2005
Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives
PT Francis, NR Sims, AW Procter, DM Bowen
Journal of neurochemistry 60 (5), 1589-1604, 1993
Presynaptic serotonergic dysfunction in patients with Alzheimer's disease
AM Palmer, PT Francis, JS Benton, NR Sims, DMA Mann, D Neary, ...
Journal of neurochemistry 48 (1), 8-15, 1987
Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer’s disease
M Garcia-Alloza, FJ Gil-Bea, M Diez-Ariza, CPLH Chen, PT Francis, ...
Neuropsychologia 43 (3), 442-449, 2005
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease
AW Procter, AM Palmer, PT Francis, SL Lowe, D Neary, E Murphy, ...
Journal of neurochemistry 50 (3), 790-802, 1988
Metals ions and neurodegeneration
F Molina-Holgado, RC Hider, A Gaeta, R Williams, P Francis
Biometals 20, 639-654, 2007
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia
KL Matthews, CPLH Chen, MM Esiri, J Keene, SL Minger, PT Francis
Biological psychiatry 51 (5), 407-416, 2002
AddNeuroMed—the European collaboration for the discovery of novel biomarkers for Alzheimer's disease
S Lovestone, P Francis, I Kloszewska, P Mecocci, A Simmons, H Soininen, ...
Annals of the New York Academy of Sciences 1180 (1), 36-46, 2009
Cholinergic deficits contribute to behavioral disturbance in patients with dementia
SL Minger, MM Esiri, B McDonald, J Keene, J Carter, T Hope, PT Francis
Neurology 55 (10), 1460-1467, 2000
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease
AM Palmer, GK Wilcock, MM Esiri, PT Francis, DM Bowen
Brain research 401 (2), 231-238, 1987
Apathy associated with neurocognitive disorders: recent progress and future directions
KL Lanctôt, L Agüera-Ortiz, H Brodaty, PT Francis, YE Geda, Z Ismail, ...
Alzheimer's & Dementia 13 (1), 84-100, 2017
Down‐regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease
SL Kirvell, M Esiri, PT Francis
Journal of neurochemistry 98 (3), 939-950, 2006
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
E Bereczki, RM Branca, PT Francis, JB Pereira, JH Baek, T Hortobágyi, ...
Brain 141 (2), 582-595, 2018
The system can't perform the operation now. Try again later.
Articles 1–20